Share This Author
ESCHERICHIA COLI STRAINS THAT CAUSE DIARRHŒA BUT DO NOT PRODUCE HEAT-LABILE OR HEAT-STABLE ENTEROTOXINS AND ARE NON-INVASIVE
Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality
- D. Nalin
- MedicineThe Yale Journal of Biology and Medicine
Key findings include evidence favoring rejection of causal linkage between encephalopathy, sudden infant death syndrome (SIDS) or infantile spasms and DT or Td (or T separately) and between early onset H. influenzae b disease and related conjugate vaccines.
Immunity to Enterotoxigenic Escherichia coli
- M. Levine, D. Nalin, D. Hoover, E. Bergquist, R. Hornick, C. Young
- Medicine, BiologyInfection and immunity
- 1 March 1979
These studies demonstrate that prior disease due to enterotoxigenic E. coli confers homologous immunity against subsequent challenge, and the operative mechanism apparently is not bactericidal and is not mediated by serum anti-O antibodies.
Control of hepatitis A through routine vaccination of children.
CONTEXT The impact of routine hepatitis A vaccination of children living in large communities with elevated disease rates has not been evaluated. OBJECTIVE To determine the effect of routine…
Ivermectin for human strongyloidiasis and other intestinal helminths.
- C. Náquira, G. Jiménez, M. Aziz
- Medicine, BiologyThe American journal of tropical medicine and…
- 1 March 1989
Overall cure rates at all doses 30 days after therapy averaged 88% for strongyloidiasis, 100% for ascariasis, 85% for trichuriasis, and 85%for enterobiasis; Ancylostoma duodenale and Necator americanus were little affected.
Fever as an adverse event following immunization: case definition and guidelines of data collection, analysis, and presentation.
Duration of infection-derived immunity to cholera.
- M. Levine, R. Black, M. Clements, L. Cisneros, D. Nalin, C. Young
- Medicine, BiologyThe Journal of infectious diseases
- 1 June 1981
The impressive duration of infection-derived immunity suggests that the most promising approach to development of cholera vaccines may be to mimic natural immunity with orally administered, attenuated strains of V. cholerae.
The pathogenicity of nonenterotoxigenic Vibrio cholerae serogroup O1 biotype El Tor isolated from sewage water in Brazil.
None of 114 stool-culture isolates yielded cholera enterotoxin, and none of the 20 volunteers had significant increases in serum titers of antitoxin as measured by enzyme-linked immunosorbent assay although six of the volunteers had slightly elevated vibriocidal antibody levels.
Oral maintenance therapy for cholera in adults.
Immunoprecipitation and virus neutralization assays demonstrate qualitative differences between protective antibody responses to inactivated hepatitis A vaccine and passive immunization with immune…
These data establish serologic correlates of protection against disease and show that RIPA is most sensitive for detection of early vaccine-induced antibody in children 4 weeks after a dose of inactivated hepatitis A vaccine.